Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $25.6 Million - $28.3 Million
233,900 New
233,900 $26.6 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $9.31 Million - $10.8 Million
96,172 Added 25852.69%
96,544 $9.34 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $9.5 Million - $11.5 Million
-93,075 Reduced 99.6%
372 $40,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $7.56 Million - $9.22 Million
66,339 Added 244.72%
93,447 $11.1 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $3.45 Million - $4.23 Million
-29,880 Reduced 52.43%
27,108 $3.82 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $2.47 Million - $2.73 Million
21,154 Added 59.03%
56,988 $6.73 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $3.77 Million - $4.44 Million
35,653 Added 19697.79%
35,834 $4.15 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $1.27 Million - $1.38 Million
-12,103 Reduced 98.53%
181 $20,000
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $444,637 - $539,979
4,852 Added 65.29%
12,284 $1.34 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $569,068 - $728,336
7,432 New
7,432 $680,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $532,573 - $642,486
-8,758 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $158,375 - $174,798
-2,751 Reduced 23.9%
8,758 $534,000
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $571,872 - $646,570
10,163 Added 755.05%
11,509 $690,000
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $5,529 - $5,919
-103 Reduced 7.11%
1,346 $77,000
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $69,638 - $77,724
1,449
1,449 $77,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.